|

Part I: Central Nervous System Neoplasms 1: Brain Metastasis 2: Glioblastoma Multiforme and High-Grade Glioma 3: Low Grade Glioma 4: Meningioma 5: Vestibular Schwannoma 6: Pituitary Tumors Central Nervous System Treatment Planning Dose Constraints
Part II: Head and Neck Cancers 7: Nasopharynx Cancer 8: Nasal Cavity and Paranasal Sinus 9: Oropharynx Cancer 10: Oral Cavity and Lip Cancers 11: Major Salivary Gland Tumors 12: Larynx and Hypopharynx Cancers 13: Thyroid Cancer 14: Occult Primary Cancer of the Head and Neck Head and Neck Treatment Planning Dose Constraints
Part III: Thoracic Cancers 15: Non-Small Cell Lung Cancer 16: Small Cell Lung Cancer 17: Mesothelioma 18: Thymoma and Thymic Carcinoma Thoracic Treatment Planning Dose Constraints
Part IV: Breast Cancer 19: Breast Cancer Breast Treatment Planning Dose Constraints
Part V: Gastrointestinal Cancers 20: Esophageal Cancer 21: Gastric Cancer 22: Hepatobiliary Cancer 23: Pancreatic Cancer 24: Rectal Cancer 25: Anal Cancer Gastrointestinal Treatment Planning Dose Constraints
Part VI: Gynecologic Cancers 26: Ovarian Cancer 27: Endometrial Cancer 28: Cervical Cancer 29: Vaginal Cancer 30: Vulvar Cancer Gynecologic Treatment Planning Dose Constraints
Part VII: Genitourinary Cancers 31: Prostate Intact 32: Adjuvant/Salvage Prostate Cancer Treatment 33: Bladder Cancer 34: Seminoma 34: Seminoma
Part VIII: Lymphoma 35: Hodgkin Lymphoma 36: Non-Hodgkin Lymphoma 37: Multiple Myeloma and Plasmacytoma 38: Cutaneous Lymphoma Lymphoma Treatment Planning Dose Constraints
Part IX: Sarcoma 39: Soft Tissue Sarcoma Sarcoma Treatment Planning Dose Constraints
Part X: Skin Cancers 40: Cutaneous Squamous Cell and Basal Cell Carcinomas 41: Malignant Melanoma 42: Merkel Cell Carcinoma
Part XI: Pediatric Malignancies 43: Ependymoma 44: Medulloblastoma 45: Neuroblastoma 46: Wilms¡¯ Tumor 47: Rhabdomyosarcoma 48: Ewing¡¯s Sarcoma 49: Pediatric Leukemia
Part XII: Metastatic Disease 50: Oligometastatic Disease 51: Palliative Radiation
Part XIII: Benign Indications 52: Benign Fibromatoses 53: Keloids 54: Heterotopic Ossification
Part XIV: Techniques 55: Proton Radiation Therapy Appendix 1:. Common Medications in Radiation Oncology Appendix 2:. Normal Tissue Tolerances Appendix 3:. Radiation and Targeted or Immunotherapeutic Agents |